Safety, Toxicity, and Regulation of Biomaterials: A Systematic Review of Global Frameworks and Emerging Challenges
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-05 · 114 (5)
DOI: 10.1002/jbm.b.70064 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 15.05.2026. Verfasst von Abhishek Rawat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Pharmacy, Amity University Noida, Noida, India. Hauptthemen laut MEDLINE: Biocompatible Materials, Materials Testing. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Biomaterials are natural or synthetic materials designed to interact with biological systems for medical, environmental, or industrial applications. Despite their expanding market and crucial healthcare role, ensuring safety and establishing consistent regulatory frameworks remains challenging. Regulatory inconsistencies impede innovation, increase development costs, and potentially compromise patient safety. To systematically examine toxicity concerns and regulatory frameworks governing biomaterials across major regions (USA, EU, India, China & Australia) and evaluate international standards from OECD and ISO organizations. We aimed to identify regulatory gaps, assess challenges posed by advanced materials, and propose solutions for harmonized global regulation. A comprehensive systematic review was conducted following PRISMA guidelines. Multiple electronic databases were searched to identify relevant studies examining biomaterial toxicity assessment methods and regulatory frameworks. Studies were screened based on predetermined eligibility criteria focusing on regulatory standards, toxicity evaluation methods, and safety protocols. Data extraction encompassed regulatory requirements, testing methodologies, and approval pathways. Analysis revealed significant regulatory heterogeneity across jurisdictions, with traditional testing methods inadequately addressing risks from advanced materials including nanomaterials and 3D‐printed tissues. Major gaps included absence of unified global approaches, insufficient evaluation methods for complex dynamic biomaterials undergoing transformation in vivo, and lack of systematic long‐term monitoring systems. Substantial improvements are achievable through innovative approaches including computational modeling for expedited approvals, smart implants incorporating embedded sensors for real‐time monitoring, and establishment of international databases to eliminate redundant testing. These recommendations could enhance regulatory efficiency, improve patient safety, and facilitate global harmonization while accelerating access to life‐saving technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Pharmacy, Amity University Noida, Noida, India.
- Department of textile and fibre engineering, Indian Institute of Technology Delhi, New Delhi, India.
ORCID-Profile: Navneet Sharma
Zitieren
APA
Rawat, A., Khanna, A., Butola, B. S., & Sharma, N. (2026). Safety, Toxicity, and Regulation of Biomaterials: A Systematic Review of Global Frameworks and Emerging Challenges. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(5). https://doi.org/10.1002/jbm.b.70064
Vancouver
Rawat A, Khanna A, Butola BS, Sharma N. Safety, Toxicity, and Regulation of Biomaterials: A Systematic Review of Global Frameworks and Emerging Challenges. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(5). doi:10.1002/jbm.b.70064
BibTeX
@article{Rawat2026,
author = {Rawat, Abhishek and Khanna, Anoushka and Butola, Bhupendra Singh and Sharma, Navneet},
title = {Safety, Toxicity, and Regulation of Biomaterials: A Systematic Review of Global Frameworks and Emerging Challenges},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2026},
volume = {114},
number = {5},
doi = {10.1002/jbm.b.70064}
}
EUVIMED